๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
MBX Biosciences, Inc. (MBX)
NASDAQ: MBX ยท Real-Time Price ยท USD
50.92
-2.49 (-4.66%)
Nov 20, 2026, 12:31 PM EST - Market open

MBX Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Income
-160.33-98.06-68.19-35.31-25.16
Net Income
-145.1-86.97-61.92-32.56-26.14
Earnings Per Share
-3.09-2.38-5.82-31.96-39.18
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
481.59373.71262.1580.6842.46
Total Debt
3.290.60.170.320.46
Net Cash (Debt)
478.3373.11261.9880.3542
Net Cash Growth
22.31%42.42%226.04%91.31%-
Net Cash Per Share
10.1910.2224.6278.8762.97

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-96.01-79.95-54.68-31.98-23.12
Capital Expenditures
-3.32-1.93-0.87-0.13-0.44
Free Cash Flow
-99.33-81.88-55.56-32.11-23.56
Free Cash Flow Growth
-----

Valuation

Selected indicators aren't available for this stock.